# FDA 483 - Dante Pieramici, M.D. - February 10, 2023

Source: https://www.globalkeysolutions.net/records/483/dante-pieramici-md/6d01ba23-a995-4a81-82cd-69bb948dbcbe

> FDA 483 for Dante Pieramici, M.D. on February 10, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dante Pieramici, M.D.
- Inspection Date: 2023-02-10
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Dante Pieramici, M.D., a clinical investigator in Santa Barbara, CA, was cited for failing to conduct an investigation in accordance with the investigational plan. The primary issue involved multiple temperature excursions for investigational product storage, affecting numerous subjects. This represents a significant deviation from protocol requirements.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.globalkeysolutions.net/companies/dante-pieramici-md/2cec9173-4c6c-4419-971c-3e1d6a0c24ea

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6